申请人:CL Pharma Aktiengesellschaft
公开号:US04927821A1
公开(公告)日:1990-05-22
The invention relates to new enol ethers of 6-chloro-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2- thiazine-3-carboxamide 1,1-dioxide of the formula ##STR1## in which R denotes (C.sub.1 -C.sub.6)-alkyl, (C.sub.5 -C.sub.7)-cycloalkyl or benzyl, and a process for their preparation. The new compounds have an antiinflammatory activity and are suitable for the treatment of rheumatism.
本发明涉及一种新型的6-氯-4-羟基-2-甲基-N-(2-吡啶基)-2H-噻吩(2,3-e)-1,2-噻二嗪-3-羧酰胺1,1-二氧化物的烯醇醚,其化学式为##STR1## 其中R表示(C.sub.1 -C.sub.6)-烷基,(C.sub.5 -C.sub.7)-环烷基或苄基。同时本发明还涉及一种制备该化合物的方法。这些新化合物具有抗炎活性,适用于治疗风湿病。